Maria Teresa Hilado
2017
In 2017, Maria Teresa Hilado earned a total compensation of $10.8M as Chief Financial Officer at Allergan, a 753% increase compared to previous year.
Compensation breakdown
| Change in Pension Value and Nonqualified Deferred Compensation Earnings | $335 |
|---|---|
| Non-Equity Incentive Plan | $2,366,250 |
| Salary | $760,993 |
| Stock Awards | $5,066,319 |
| Other | $2,567,686 |
| Total | $10,761,583 |
Hilado received $5.1M in stock awards, accounting for 47% of the total pay in 2017.
Hilado also received $335 of change in pension value and nonqualified deferred compensation earnings, $2.4M in non-equity incentive plan, $761K in salary and $2.6M in other compensation.
Rankings
In 2017, Maria Teresa Hilado's compensation ranked 561st out of 14,666 executives tracked by ExecPay. In other words, Hilado earned more than 96.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 561 out of 14,666 | 96th |
Division Manufacturing | 185 out of 5,770 | 97th |
Major group Chemicals And Allied Products | 44 out of 2,074 | 98th |
Industry group Drugs | 31 out of 1,730 | 98th |
Industry Pharmaceutical Preparations | 27 out of 1,329 | 98th |
Source: SEC filing on March 23, 2018.
Hilado's colleagues
We found four more compensation records of executives who worked with Maria Teresa Hilado at Allergan in 2017.